Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valproic acid pharmacokinetics in obesity
NCT00298857Phase 4Terminated
- Sponsor
- Northwell Health
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of valproic acid in epilepsy, migraine and bipolar disorder (BD), sponsored by Northwell Health. Primary endpoints: Area under the concentration time curve and Clearance. Started Mar 2006; status: terminated.
02
Drugs
valproic acid
03
Conditions
epilepsymigrainebipolar disorder (BD)
Beyond the preview
Go deeper on NCT00298857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00298857.